Image

Global Intra-Uterine Contraceptive Devices Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Intra-Uterine Contraceptive Devices Market, By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), Product Type (Mirena, Skyla, Paragard, Essure, Levosert, Others), End User (Hospitals, Gynaecology Clinics, Community Health Care Centers, Others) – Industry Trends and Forecast to 2029.

Intra-Uterine Contraceptive Devices Market

Global Intra-Uterine Contraceptive Devices Market Analysis and Size

In the recent years, more than a half of the pregnancies are unwanted, unintended and mistimed. Various governments and non-profit organizations are increasing initiatives to promote the use of IUDs. Various awareness programmes are being organized to educate people regarding birth control measures and family planning.

  • Global intra-uterine contraceptive devices market was valued at USD 4.09 billion in 2021 and is expected to reach USD 6.00 billion by 2029, registering a CAGR of 4.70% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Intra-Uterine Contraceptive Devices Market Definition

Intrauterine devices (IUDs) are defined as copper birth control or small T-shaped plastic devices that are inserted into the uterus. These devices are known to prevent pregnancy as it stops sperm from reaching and fertilizing the eggs. These devices are being highly deployed as they are considered safe, long-acting, effective and eliminating the need for other contraceptives.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Hormonal Intrauterine Device, Copper Intrauterine Device), Product Type (Mirena, Skyla, Paragard, Essure, Levosert, Others), End User (Hospitals, Gynecology Clinics, Community Health Care Centers, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Teva Pharmaceutical Industries Ltd. (Jerusalem), Bayer (Germany), EUROGINE (Spain), CooperSurgical Inc. (US), Pfizer Inc. (US), HLL Lifecare Limited (Thiruvananthapuram), OCON Medical Ltd. (Israel), Prosan International BV (Netherlands), Melbea Innovations (Hungary), Allergan, Merck & Co., Inc. (US), DKT International (US), Medisafe Distribution Inc. (Canada), Medicines360 (US), Pregna International Limited (India), and Egemen International (Turkey),  among others

Intra-Uterine Contraceptive Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Rise in Awareness

The rise in awareness regarding the birth control measures and family planning across the globe acts as one of the major factors driving the growth of intra-uterine contraceptive devices market.

  • Initiatives by Government

The increase in the initiatives by several governments and non-profit organizations to promote the use of IUDs accelerate the market growth.

  • Affordable Care Act (ACA)

The repealing Affordable Care Act (ACA) in the United States encouraging large section of women to choose for long-acting reversible contraception (LARC) owing to the lack of access to abortion further influence the market.

Opportunities

Furthermore, technological innovations leading to effective contraception and fewer side effects extend profitable opportunities to the market players in the forecast period of 2022 to 2029.

Restraints/Challenges Global Intra-Uterine Contraceptive Devices Market

On the other hand, common risks associated with intrauterine contraceptive devices such as, infections, damage to the uterus and severe cramping, among others are expected to obstruct market growth. Also, stringent regulations and reimbursement policies are projected to challenge the intra-uterine contraceptive devices market in the forecast period of 2022-2029.

This intra-uterine contraceptive devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on intra-uterine contraceptive devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Intra-Uterine Contraceptive Devices Market

The COVID-19 pandemic had an impact on the health systems across the globe, disrupting access to family planning information and services, also affecting intra-uterine contraceptive devices market. The need for family planning remains the same despite this disruption as family planning is critical health care for women. Governments were working with global partners in order to ensure family planning remains an essential element of the global health agenda during pandemic, as well as post-pandemic.

Recent Development

  • Sebela Pharmaceuticals Inc., collaborated with PRA Health Sciences to conduct a phase III clinical trial to assess LevoCept in June’2021. The product is a long-acting reversible intrauterine system for contraceptive safety, tolerability and efficacy. The trial is going to be completed in June’2027.

Global Intra-Uterine Contraceptive Devices Market Scope and Market Size

The intra-uterine contraceptive devices market is segmented on the basis of type, product type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Hormonal Intrauterine Device
  • Copper Intrauterine Device

On the basis of type, the intra-uterine contraceptive devices market is segmented into hormonal intrauterine device and copper intrauterine device.

Product Type

  • Mirena
  • Skyla
  • Paragard
  • Essure
  • Levosert
  • Others

Intra-uterine contraceptive devices market can is segmented on the basis of product type into mirena, skyla, paragard, essure, levosert and others.

End User

  • Hospitals
  • Gynecology Clinics
  • Community Health Care Centers
  • Others

The end user segment of intra-uterine contraceptive devices market is segmented into hospitals, gynecology clinics, community health care centers and others.

Intra-Uterine Contraceptive Devices Market Regional Analysis/Insights

The intra-uterine contraceptive devices market is analysed and market size insights and trends are provided by country, type, product type and end user as referenced above.

The countries covered in the intra-uterine contraceptive devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the intra-uterine contraceptive devices market because of the technological advancements in intrauterine contraceptive devices within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in awareness among the woman population in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The intra-uterine contraceptive devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intra-uterine contraceptive devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intra-uterine contraceptive devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Intra-Uterine Contraceptive Devices Market Share Analysis

The intra-uterine contraceptive devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intra-uterine contraceptive devices market.

Some of the major players operating in the intra-uterine contraceptive devices market are Teva Pharmaceutical Industries Ltd. (Jerusalem), Bayer (Germany), EUROGINE (Spain), CooperSurgical Inc. (US), Pfizer Inc. (US), HLL Lifecare Limited (Thiruvananthapuram), OCON Medical Ltd. (Israel), Prosan International BV (Netherlands), Melbea Innovations (Hungary), Allergan, Merck & Co., Inc. (US), DKT International (US), Medisafe Distribution Inc. (Canada), Medicines360 (US), Pregna International Limited (India), and Egemen International (Turkey),  among others.

Research Methodology : Global Intra-Uterine Contraceptive Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-intra-uterine-contraceptive-devices-market

Customization Available : Global Intra-Uterine Contraceptive Devices Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Intra-Uterine Contraceptive Devices Market will be projected at USD 6.00 billion during the forecast period of 2022 to 2029.
The Intra-Uterine Contraceptive Devices Market is Expected to Witness CAGR of 4.70% During the Forecast Period of 2022 to 2029.
The Major Players Operating in the Intra-Uterine Contraceptive Devices Market are Teva Pharmaceutical Industries Ltd. (Jerusalem), Bayer (Germany), EUROGINE (Spain), CooperSurgical Inc. (US), Pfizer Inc. (US), HLL Lifecare Limited (Thiruvananthapuram), OCON Medical Ltd. (Israel), Prosan International BV (Netherlands), among others.
The Countries Covered in the Intra-Uterine Contraceptive Devices Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Intra-Uterine Contraceptive Devices Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.